Symbols

CVS

CVS Health·NYSE

--(--)

CVS fundamentals

CVS Q4 2025 Earnings

CVS Health (CVS) released its earnings on Feb 10, 2026: revenue was 105.69B (YoY +8.17%), beat estimates; EPS was 1.09 (YoY -8.40%), beat estimates.

Revenue / YoY

105.69B

+8.17%

EPS / YoY

1.09

-8.40%

Report date

Feb 10, 2026

CVS Earnings Call Summary for Q4,2025

Record Financial Performance: 2025 EPS $6.75 vs. initial guidance, 2026 EPS reaffirmed at $7-$7.20.
Aetna Turnaround: $2.6B+ op. income improvement, leading Stars rating, and first-time industry award.
Pharmacy Growth: Script share 29%, same-store pharmacy sales +19%, CVS Pharmacy flat earnings guidance.
Medicare Advocacy: CMS rate notice 8.5% below trend, but 2026 margin improvement on track.
Strategic Investments: $100M+ AI spend, open engagement platform pilot, and biosimilar savings $1.2B+.

Earnings

EPS

Revenue

Revenue & Expenses

CVS has released its 2025 Q4 earnings report, with revenue of 105.69B, reflecting a YoY change of 8.17%, and net profit of 2.92B, showing a YoY change of 80.10%. The Sankey diagram below clearly presents CVS's revenue sources and cost distribution.

Key Indicators

CVS Health (CVS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

CVS Health (CVS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

CVS Health (CVS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

CVS Health (CVS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown